source
- Vertex to buy Crinetics for $10 billion, expanding into endocrine disease drugsVertex announced an agreement to acquire Crinetics Pharmaceuticals for $10 billion in cash, paying $85 per share. The purchase brings two recently launched drugs for a rare hormonal disorder into…
- CMS launches ACCESS program to reward Medicare digital health solutions that improve outcomesThe Centers for Medicare & Medicaid Services introduced the ACCESS program, a new initiative that invites digital health companies to participate in Medicare. The program ties Medicare payments to…